N-Succinyl-Ala-Ala-Phe-7-amido-4-methylcoumarin

N-Succinyl-Ala-Ala-Phe-7-amido-4-methylcoumarin links a protected peptide substrate to a fluorogenic reporter for monitoring enzymatic cleavage. Phenylalanine enhances hydrophobic recognition and substrate affinity. Researchers assess kinetic performance in fluorescence-based assays. Applications include protease profiling, substrate development, and mechanistic enzyme analysis.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
N-Succinyl-Ala-Ala-Phe-7-amido-4-methylcoumarin(CAS 71973-79-0)

CAT No: R2474

CAS No:71973-79-0

Synonyms/Alias:N-Succinyl-Ala-Ala-Phe-7-amido-4-methylcoumarin;71973-79-0;4-[[1-[[1-[[1-[(4-methyl-2-oxochromen-7-yl)amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid;DTXSID90390826;DTXCID00341687;DA-78073;N-Succinyl-Ala-Ala-Phe-7-amido-4-methylcoumarin, protease substrate;635-336-2;

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C29H32N4O8
M.W/Mr.
564.6
Sequence
One Letter Code:AAF
Three Letter Code:Suc-DL-Ala-DL-Ala-DL-Phe-AMC

N-Succinyl-Ala-Ala-Phe-7-amido-4-methylcoumarin, also known as Suc-Ala-Ala-Phe-AMC, is a synthetic peptide substrate widely recognized for its utility in biochemical and enzymatic assays. Featuring a peptide backbone conjugated to the fluorescent moiety 7-amido-4-methylcoumarin (AMC), this compound enables sensitive detection of protease activity, particularly those enzymes that cleave after phenylalanine residues. Its structure facilitates rapid and specific hydrolysis by target proteases, releasing the highly fluorescent AMC group, which can be easily quantified using standard fluorometric techniques. Due to its robust signal generation and compatibility with various assay platforms, Suc-Ala-Ala-Phe-AMC has become an indispensable reagent in the study of proteolytic enzymes and their inhibitors.

Protease Activity Assays: N-Succinyl-Ala-Ala-Phe-7-amido-4-methylcoumarin is extensively employed in the quantitative analysis of protease activity, especially for chymotrypsin-like serine proteases. Researchers utilize this substrate to monitor enzymatic cleavage events by measuring the increase in fluorescence as the AMC group is liberated. The high specificity of the peptide sequence ensures selective recognition by target proteases, making it an ideal choice for kinetic studies, enzyme characterization, and inhibitor screening. Its use streamlines the evaluation of enzyme kinetics, allowing for accurate calculation of parameters such as Km and Vmax without interference from non-specific hydrolysis.

Enzyme Inhibitor Screening: Suc-Ala-Ala-Phe-AMC serves as a critical tool in the identification and evaluation of protease inhibitors. By incorporating this substrate into high-throughput screening assays, scientists can rapidly assess the efficacy of candidate compounds in suppressing proteolytic activity. The sensitive fluorescence-based readout enables detection of even subtle inhibitory effects, facilitating the discovery of potent and selective inhibitors for therapeutic or research applications. Its compatibility with automated platforms and multi-well formats further enhances throughput and reproducibility, supporting large-scale inhibitor profiling campaigns.

Biochemical Pathway Elucidation: The substrate is also instrumental in dissecting complex biochemical pathways involving proteolytic processing. By applying Suc-Ala-Ala-Phe-AMC in cell-free systems or purified enzyme preparations, investigators can delineate the roles of specific proteases in regulatory cascades. The ability to monitor real-time protease activity provides insights into substrate specificity, enzyme activation mechanisms, and the modulation of proteolytic events by cofactors or interacting proteins. This approach aids in mapping protease networks and understanding their functional significance in physiological and pathological contexts.

Pharmaceutical Research: In drug discovery and pharmaceutical development, N-Succinyl-Ala-Ala-Phe-7-amido-4-methylcoumarin is frequently utilized to evaluate the impact of novel compounds on protease function. Its use in preclinical research supports the selection and optimization of drug candidates targeting proteolytic enzymes implicated in various diseases. The substrate's robust performance in fluorescence-based assays enables precise measurement of compound potency, selectivity, and mechanism of action, thereby accelerating the drug development process and guiding structure-activity relationship studies.

Diagnostic Assay Development: Suc-Ala-Ala-Phe-AMC contributes significantly to the design and validation of diagnostic assays for detecting protease activity in biological samples. Its high sensitivity and specificity make it suitable for developing assays that monitor disease-associated changes in protease expression or function. By incorporating this substrate into diagnostic platforms, researchers can achieve rapid and reliable detection of proteolytic biomarkers, supporting early diagnosis, disease monitoring, and research into pathophysiological mechanisms. The versatility of this compound allows adaptation to various assay formats, including microplate, flow cytometry, and imaging-based systems.

Academic Research and Method Development: Beyond its established roles in enzymology and pharmaceutical screening, N-Succinyl-Ala-Ala-Phe-7-amido-4-methylcoumarin is widely adopted in academic research for the development of new analytical methodologies. Scientists leverage its well-characterized fluorescence properties to optimize assay protocols, calibrate detection instruments, and validate novel approaches for studying protease activity. Its application extends to comparative studies of enzyme families, investigation of substrate specificity determinants, and exploration of structure-function relationships in proteolytic systems. By providing a reliable and sensitive means of monitoring protease activity, this substrate continues to advance our understanding of enzymatic processes and supports innovation in biochemical research.

InChI
InChI=1S/C29H32N4O8/c1-16-13-26(37)41-23-15-20(9-10-21(16)23)32-29(40)22(14-19-7-5-4-6-8-19)33-28(39)18(3)31-27(38)17(2)30-24(34)11-12-25(35)36/h4-10,13,15,17-18,22H,11-12,14H2,1-3H3,(H,30,34)(H,31,38)(H,32,40)(H,33,39)(H,35,36)
InChI Key
HHPVJKZZYOXPLH-UHFFFAOYSA-N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Nucleic Acids SynthesisPeptide Analysis ServicescGMP Peptide ServicePeptide Synthesis ServicesCustom Conjugation ServiceEpitope Mapping ServicesPeptide Modification ServicesPeptide CDMO
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers